Antimicrobials News

Findings from a study conducted at nearly 600 nursing homes in Ontario found that high urine culturing rates were associated with increased total antibiotic use, Clostridiodes difficile infection and 30-day mortality, researchers reported.

Infants aged 60 days or younger with UTIs caused by Escherichia coli or Klebsiella pneumoniae who were treated with narrow-spectrum antibiotics were no more likely to relapse or require a longer duration of antibiotics than infants who were treated with broad-spectrum agents, according to a retrospective cohort study published in the Journal of the Pediatric Infectious Diseases Society.

SAN FRANCISCO — Cannabidiol, or CBD, showed surprising effectiveness against gram-positive bacteria in vitro, including some that were resistant to vancomycin and daptomycin, according to research presented at ASM Microbe.

SAN FRANCISCO — Bacteriophages may be living in household kitchen sponges, according to data presented at ASM Microbe.

SAN FRANCISCO — Researchers compared current whole genome sequencing methods with a new PCR diagnostic test and found that the new test provided quicker results, allowing testing during an outbreak to begin immediately, according to data presented at ASM Microbe.

SAN FRANCISCO — A novel research program allows students to contribute to the ongoing search for new antibiotics through studying soil samples and conducting hands-on research.

SAN FRANCISCO — A genetic analysis of Bacillus strains found in probiotic products that researchers purchased at a supermarket showed that some are resistant to antibiotics, according to data presented at ASM Microbe.

WHO today announced a global campaign to promote its AWaRe antimicrobials classification index, with the hope that more countries will adopt the tool to reduce the spread of resistance.

PHILADEPHIA — A new protocol implemented to treat patients with sepsis reduced the time that they were on broad-spectrum antibiotics, decreased their length of stay and saved a hospital in Pennsylvania over $300,000 in 4 months, according to findings presented at the conference for the Association for Professionals in Infection Control Epidemiology.

Approximately 1 million treatment courses of new tuberculosis medicines designed for easy administration in children have been ordered by 93 countries since they were first introduced in 2016, according to the nonprofit organization TB Alliance.